Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...

Gemini 2.5 Pro Experimental boosts accuracy by reasoning before responding, available in Google AI Studio and for Gemini ...

Nvidia has invested in a startup founded by a former Google DeepMind senior research scientist who specialized in robotics ...

Over the next decade, advances in artificial intelligence will mean that humans will no longer be needed "for most things" in ...